First 90 Days: Editas Medicine’s Gilmore O’Neill

Welcome to First 90 Days, a series dedicated to examining how pharma executives are planning for success in their new role. Today, we’re looking at Editas Medicine’s CEO, Gilmore O’Neill, who stepped into the role at the beginning of June to take the gene editing company to the next level in its biotech journey. Editas … Read more